Frankfurt - Delayed Quote • EUR Spero Therapeutics, Inc. (2HA.F) Follow Compare 0.7160 -0.0540 (-7.01%) As of 9:59:02 AM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 2HA.F 1D 5D -15.17% 1M -23.18% 3M -41.31% 6M -38.59% YTD -26.03% 1Y -46.73% 5Y -92.00% All -92.94% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 2HA.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes Here's Why Arcutis Stock More Than Doubled in Market Value in One Year CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA Neumora Stock Hits Record Low on Depression Drug Study Failure EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday JANX Stock Hits Record High on Prostate Cancer Study Data PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy Grifols Stock Declines After Brookfield Drops Buyout Offer Related Tickers ORGS Orgenesis Inc. 1.7000 +12.58% HOOK HOOKIPA Pharma Inc. 1.8900 0.00% ONCO Onconetix, Inc. 0.5464 -0.31% LXRX Lexicon Pharmaceuticals, Inc. 0.7180 +3.30% ATAI Atai Life Sciences N.V. 2.2600 -11.42% RXRX Recursion Pharmaceuticals, Inc. 8.06 -3.42%